Gangjun Du

1.2k total citations
35 papers, 846 citations indexed

About

Gangjun Du is a scholar working on Molecular Biology, Cancer Research and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Gangjun Du has authored 35 papers receiving a total of 846 indexed citations (citations by other indexed papers that have themselves been cited), including 19 papers in Molecular Biology, 8 papers in Cancer Research and 5 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Gangjun Du's work include Cancer, Hypoxia, and Metabolism (6 papers), Ginger and Zingiberaceae research (3 papers) and Immune cells in cancer (3 papers). Gangjun Du is often cited by papers focused on Cancer, Hypoxia, and Metabolism (6 papers), Ginger and Zingiberaceae research (3 papers) and Immune cells in cancer (3 papers). Gangjun Du collaborates with scholars based in China and Czechia. Gangjun Du's co-authors include Haihong Lin, Linlin Lu, Lijuan Yu, Guang Han, Mei Wang, Shuo Zhang, Weijie Liu, Jiahuan Li, Zhenzhen Guo and Shuo Zhang and has published in prestigious journals such as PLoS ONE, Journal of Agricultural and Food Chemistry and Biochemical and Biophysical Research Communications.

In The Last Decade

Gangjun Du

34 papers receiving 825 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Gangjun Du China 19 393 116 115 109 84 35 846
Youn Kyung Choi South Korea 19 440 1.1× 133 1.1× 157 1.4× 152 1.4× 91 1.1× 36 957
Mi‐Young Jeong South Korea 19 538 1.4× 86 0.7× 78 0.7× 88 0.8× 68 0.8× 35 1.1k
Shin‐Hyung Park South Korea 19 557 1.4× 130 1.1× 162 1.4× 116 1.1× 104 1.2× 57 1.1k
Shaoyu Wu China 16 536 1.4× 156 1.3× 161 1.4× 101 0.9× 58 0.7× 54 1.0k
Ji‐Ye Kee South Korea 18 460 1.2× 133 1.1× 163 1.4× 88 0.8× 165 2.0× 37 901
Xiaominting Song China 8 400 1.0× 104 0.9× 55 0.5× 97 0.9× 75 0.9× 11 846
Xiuli Bi China 20 737 1.9× 122 1.1× 107 0.9× 92 0.8× 69 0.8× 48 1.2k
Muhamad Noor Alfarizal Kamarudin Malaysia 17 429 1.1× 123 1.1× 93 0.8× 86 0.8× 51 0.6× 31 873
Xueting Deng China 14 447 1.1× 196 1.7× 174 1.5× 88 0.8× 110 1.3× 28 1.1k
Yuxin Li China 22 643 1.6× 163 1.4× 151 1.3× 93 0.9× 143 1.7× 68 1.2k

Countries citing papers authored by Gangjun Du

Since Specialization
Citations

This map shows the geographic impact of Gangjun Du's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Gangjun Du with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Gangjun Du more than expected).

Fields of papers citing papers by Gangjun Du

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Gangjun Du. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Gangjun Du. The network helps show where Gangjun Du may publish in the future.

Co-authorship network of co-authors of Gangjun Du

This figure shows the co-authorship network connecting the top 25 collaborators of Gangjun Du. A scholar is included among the top collaborators of Gangjun Du based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Gangjun Du. Gangjun Du is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Peng, Xi, Yaru Zhang, Wenwen Li, et al.. (2022). The mechanism of dioscin preventing lung cancer based on network pharmacology and experimental validation. Journal of Ethnopharmacology. 292. 115138–115138. 23 indexed citations
3.
Gu, Wenwen, Mengdi Zhang, Wenwen Li, et al.. (2022). Berberine regulates PADI4-related macrophage function to prevent lung cancer. International Immunopharmacology. 110. 108965–108965. 29 indexed citations
4.
Li, Wenwen, et al.. (2022). Integrating network pharmacology and transcriptomic validation to investigate the efficacy and mechanism of Mufangji decoction preventing lung cancer. Journal of Ethnopharmacology. 298. 115573–115573. 14 indexed citations
5.
Zhou, Lin, Wenwen Gu, Wenwen Li, et al.. (2021). The mechanism and candidate compounds of aged citrus peel (chenpi) preventing chronic obstructive pulmonary disease and its progression to lung cancer. Food & Nutrition Research. 65. 25 indexed citations
6.
Wang, Yuehua, Wenwen Gu, Wenwen Li, et al.. (2021). The mechanism and active compounds of semen armeniacae amarum treating coronavirus disease 2019 based on network pharmacology and molecular docking. Food & Nutrition Research. 65. 14 indexed citations
7.
Wang, Zhen, Gangjun Du, Yiguang Jin, et al.. (2020). Enhanced anticancer efficacy of cantharidin by mPEG-PLGA micellar encapsulation: An effective strategy for application of a poisonous traditional Chinese medicine. Colloids and Surfaces B Biointerfaces. 196. 111285–111285. 18 indexed citations
8.
Zhang, Shuhui, Yukun Lin, Lin Zhou, et al.. (2019). Momordicoside G Regulates Macrophage Phenotypes to Stimulate Efficient Repair of Lung Injury and Prevent Urethane-Induced Lung Carcinoma Lesions. Frontiers in Pharmacology. 10. 321–321. 5 indexed citations
9.
Lin, Yukun, Shuhui Zhang, Lin Zhou, et al.. (2019). Emodin regulates neutrophil phenotypes to prevent hypercoagulation and lung carcinogenesis. Journal of Translational Medicine. 17(1). 90–90. 37 indexed citations
10.
Guo, Zhenzhen, Mingjing Meng, Zhenhua Du, et al.. (2016). The optimal dose of arsenic trioxide induced opposite efficacy in autophagy between K562 cells and their initiating cells to eradicate human myelogenous leukemia. Journal of Ethnopharmacology. 196. 29–38. 10 indexed citations
11.
Cao, Ning, Zhenzhen Guo, Yaqiu Zheng, et al.. (2015). Lasting glycolytic stress governs susceptibility to urethane-induced lung carcinogenesis in vivo and in vitro. Toxicology Letters. 240(1). 130–139. 8 indexed citations
12.
Du, Gangjun, et al.. (2013). Hypothermic microenvironment plays a key role in tumor immune subversion. International Immunopharmacology. 17(2). 245–253. 24 indexed citations
13.
Du, Gangjun, Yaping Zhang, Ting Sun, et al.. (2013). Thrombocytosis and immunohistochemical expression of connexin 43 at diagnosis predict survival in advanced non-small-cell lung cancer treated with cisplatin-based chemotherapy. Cancer Chemotherapy and Pharmacology. 71(4). 893–904. 29 indexed citations
14.
Du, Gangjun, Bei Zhao, Yaping Zhang, et al.. (2013). Hypothermia Activates Adipose Tissue to Promote Malignant Lung Cancer Progression. PLoS ONE. 8(8). e72044–e72044. 17 indexed citations
15.
Du, Gangjun, Ting Sun, Ya‐Ping Zhang, et al.. (2013). The mitochondrial dysfunction plays an important role in urethane-induced lung carcinogenesis. European Journal of Pharmacology. 715(1-3). 395–404. 21 indexed citations
16.
Du, Gangjun, Jiahuan Li, Weijie Liu, et al.. (2013). The combination of TRPM8 and TRPA1 expression causes an invasive phenotype in lung cancer. Tumor Biology. 35(2). 1251–1261. 46 indexed citations
17.
Du, Gangjun, Haihong Lin, Yiming Yang, et al.. (2010). Dietary quercetin combining intratumoral doxorubicin injection synergistically induces rejection of established breast cancer in mice. International Immunopharmacology. 10(7). 819–826. 62 indexed citations
18.
Du, Gangjun, Guang Han, Shuo Zhang, et al.. (2009). Baicalin suppresses lung carcinoma and lung metastasis by SOD mimic and HIF-1α inhibition. European Journal of Pharmacology. 630(1-3). 121–130. 62 indexed citations
19.
Du, Gangjun, Zhihui Song, Haihong Lin, et al.. (2008). Luteolin as a glycolysis inhibitor offers superior efficacy and lesser toxicity of doxorubicin in breast cancer cells. Biochemical and Biophysical Research Communications. 372(3). 497–502. 45 indexed citations
20.
Wang, Lili, Jinjun Li, Zhibing Zheng, et al.. (2004). Antitumor activities of a novel indolin-2-ketone compound, Z24: more potent inhibition on bFGF-induced angiogenesis and bcl-2 over-expressing cancer cells. European Journal of Pharmacology. 502(1-2). 1–10. 32 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Youn Kyung Choi Breakdown of academic impact, for papers by Mi‐Young Jeong Breakdown of academic impact, for papers by Shin‐Hyung Park Breakdown of academic impact, for papers by Shaoyu Wu Breakdown of academic impact, for papers by Ji‐Ye Kee Breakdown of academic impact, for papers by Xiaominting Song Breakdown of academic impact, for papers by Xiuli Bi Breakdown of academic impact, for papers by Muhamad Noor Alfarizal Kamarudin Breakdown of academic impact, for papers by Xueting Deng Breakdown of academic impact, for papers by Yuxin Li
Rankless by CCL
2026